Search Results 241-250 of 17414 for bronchiolitis

  1. A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination with Crizotinib - Mayo Clinic

    About this study. The purpose of the study is to evaluate safety and efficacy of AT13387 Alone and in Combination with Crizotinib in the Treatment of ...

  2. Pulmonary Medicine Clinical Trials - Medical Professionals

    Rochester, Minn., Scottsdale/Phoenix, Ariz. The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the ...

  3. Pulmonary Medicine Clinical Trials - Medical Professionals

    Jacksonville, Fla. The purpose of this study is to evaluate Lamprene (Clofazimine) to treat non-tuberculous mycobacterial (NTM) infections. Post Approval Study ...

  4. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

    History of idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), drug-induced pneumonitis, or idiopathic pneumonitis, or ...

  5. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    History of idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), drug-induced pneumonitis, idiopathic pneumonitis, or evidence ...

  6. COPD - Doctors and departments - Mayo Clinic

    This ongoing lung disease limits airflow into and out of the lungs. This results in trouble breathing, cough with mucus and wheezing.

  7. A Study to Evaluate Biomarker/ALK Inhibitor Combinations in Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol) - Mayo Clinic

    History of interstitial lung disease or interstitial fibrosis, including a history of pneumonitis, obliterative bronchiolitis, pulmonary fibrosis. Patients ...

  8. Pulmonary Medicine - Doctors - Mayo Clinic

    Learn about the expertise and wide range of services at Mayo Clinic for people with complex or serious conditions that affect the lungs and breathing.

  9. Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis - Mayo Clinic

    The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...

  10. A Study to Treat Chronic Rhinosinusitis by Transplanting Probiotic Communites - Mayo Clinic

    The purpose of this study is to identify differences in the sinus microbiota in patients with chronic rhinosinusitis (CRS) and determine potential immunological ...